n.a. (MRX)

0.00
NYSE
Prev Close 0.00
Day Low/High 0.00 / 0.00
52 Wk Low/High 0.00 / 0.00
Exchange NYSE
Div & Yield N.A. (N.A)

Latest News

Medicis Pharmaceuticals Corporation (MRX): Today's Featured Drugs Laggard

Medicis Pharmaceuticals Corporation (MRX): Today's Featured Drugs Laggard

Medicis Pharmaceuticals Corporation was a leading decliner within the drugs industry, falling $1.32 (-3%) to $42.03 on heavy volume.

Medicis Stock To Go Ex-dividend Tomorrow (MRX)

Medicis Stock To Go Ex-dividend Tomorrow (MRX)

The ex-dividend date for Medicis Pharmaceuticals Corporation (NYSE:MRX) is tomorrow, September 27, 2012. Owners of shares as of market close today will be eligible for a dividend of 10 cents per share. At a price of $43.34 as of 9:30 a.m., the dividend yield is 0.9%.

Medicis Declares Cash Dividend

Medicis Declares Cash Dividend

Law Office Of Brodsky & Smith, LLC Announces Investigation Of Medicis Pharmaceutical Corporation

Law Office Of Brodsky & Smith, LLC Announces Investigation Of Medicis Pharmaceutical Corporation

Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Medicis Pharmaceutical Corporation (“Medicis” or the “Company”) (NYSE-MRX) ...

Faruqi & Faruqi, LLP Is Seeking More Cash For The Shareholders Of Medicis Pharmaceutical Corp. (MRX)

Faruqi & Faruqi, LLP Is Seeking More Cash For The Shareholders Of Medicis Pharmaceutical Corp. (MRX)

Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Medicis Pharmaceutical Corp.

Law Office Of Brodsky & Smith, LLC Announces Investigation Of Medicis Pharmaceutical Corporation

Law Office Of Brodsky & Smith, LLC Announces Investigation Of Medicis Pharmaceutical Corporation

Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Medicis Pharmaceutical Corporation (“Medicis” or the “Company”) (NYSE:MRX) ...

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation Into Possible Breaches Of Fiduciary Duty By The Board Of Medicis Pharmaceutical Corporation In Connection With The Sale Of The Company To Valeant Pharmaceuticals International, Inc.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation Into Possible Breaches Of Fiduciary Duty By The Board Of Medicis Pharmaceutical Corporation In Connection With The Sale Of The Company To Valeant Pharmaceuticals International, Inc.

Levi & Korsinsky is investigating the Board of Directors of Medicis Pharmaceutical Corporation (“Medicis” or the “Company”) (NYSE: MRX) for possible breaches of fiduciary duty and other violations...

Ryan & Maniskas, LLP Announces Investigation Of Medicis Pharmaceutical Corp.

Ryan & Maniskas, LLP Announces Investigation Of Medicis Pharmaceutical Corp.

Ryan & Maniskas, LLP ( www.rmclasslaw.

Securities Lawyers Seeking More Money, Information For Stockholders Of Medicis At Goldfarb LLP

Securities Lawyers Seeking More Money, Information For Stockholders Of Medicis At Goldfarb LLP

Securities lawyers at Goldfarb LLP are investigating alleged violations of shareholder protection laws by officers and directors of Medicis Pharmaceutical Corporation (NYSE: MRX) in connection with a buyout for $44...

Cramer's 'Mad Money' Recap: The Worse It Gets, the Better

Cramer's 'Mad Money' Recap: The Worse It Gets, the Better

Cramer doesn't want to flee the market and thinks you shouldn't either.

Faruqi & Faruqi, LLP Is Seeking More Cash For The Shareholders Of Medicis Pharmaceutical Corp. (MRX)

Faruqi & Faruqi, LLP Is Seeking More Cash For The Shareholders Of Medicis Pharmaceutical Corp. (MRX)

Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Medicis Pharmaceutical Corp.

Stocks Start September With Mixed Finish

Stocks Start September With Mixed Finish

The Dow and S&P 500 close lower, weighed down by disappointing manufacturing data, while the Nasdaq manages a slight gain as Apple rallies.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation Into Possible Breaches Of Fiduciary Duty By The Board Of Medicis Pharmaceutical Corporation In Connection With The Sale Of The Company To Valeant Pharmaceuticals International, Inc.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation Into Possible Breaches Of Fiduciary Duty By The Board Of Medicis Pharmaceutical Corporation In Connection With The Sale Of The Company To Valeant Pharmaceuticals International, Inc.

Levi & Korsinsky is investigating the Board of Directors of Medicis Pharmaceutical Corporation (“Medicis” or the “Company”) (NYSE: MRX) for possible breaches of fiduciary duty and other violations...

Pomerantz Law Firm Investigates Claims On Behalf Of Investors Of Medicis Pharmaceutical Corporation

Pomerantz Law Firm Investigates Claims On Behalf Of Investors Of Medicis Pharmaceutical Corporation

Pomerantz Grossman Hufford Dahlstrom & Gross LLP is investigating claims on behalf of investors of Medicis Pharmaceutical Corporation (“Medicis” or the “Company”) (NYSE: MRX) (ISIN: US5846903095)...

Holzer Holzer & Fistel, LLC Announces Investigation Into The Proposed Buyout Of Medicis Pharmaceutical Corporation

Holzer Holzer & Fistel, LLC Announces Investigation Into The Proposed Buyout Of Medicis Pharmaceutical Corporation

Holzer Holzer & Fistel, LLC is investigating whether the directors of Medicis Pharmaceutical Corporation (“Medicis” or the “Company”) (NYSE: MRX) complied with their fiduciary duties in approving...

Medicis Pharmaceutical Shareholder Alert: The Briscoe Law Firm And Powers Taylor, LLP Investigate Sale Of Medicis Pharmaceutical To Valeant Pharmaceuticals International, Inc.

Medicis Pharmaceutical Shareholder Alert: The Briscoe Law Firm And Powers Taylor, LLP Investigate Sale Of Medicis Pharmaceutical To Valeant Pharmaceuticals International, Inc.

Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor, LLP are investigating the sale of Medicis Pharmaceutical Corporation...

Kendall Law Group Investigates Medicis Pharmaceutical Corp.

Kendall Law Group Investigates Medicis Pharmaceutical Corp.

Kendall Law Group, led by former federal judge Joe Kendall, is investigating Medicis Pharmaceutical Corp.

Stock Futures Waver Ahead of Manufacturing Report

Stock Futures Waver Ahead of Manufacturing Report

Stock futures are meandering coming out of the extended Labor Day holiday weekend.

Morning Briefing: 10 Things You Should Know

Morning Briefing: 10 Things You Should Know

U.S. stock futures are higher; Mario Draghi indicates ECB could buy shorter-dated bonds; Valeant to buy Medicis.